. Eleven compounds that have ER binding at AC 50 < 1 µM for all the three mammalian nuclear receptor binding assays were also active in the uterotrophic assay. They also belong to the training set data used to derive the ER QSAR model. The in silico prediction results including the total domain information as well as in vitro assay data are given
. Eleven compounds that have ER binding at AC 50 < 1 µM for all the three mammalian nuclear receptor binding assays were also active in the uterotrophic assay. They also belong to the training set data used to derive the ER QSAR model. The in silico prediction results including the total domain information as well as in vitro assay data are given Table 3c . Four compounds (3 Phthalates and 1 Kaempferol) belonging to the training set were considered active in the ER in vitro assay used to derive the model but where inactive in uterotrophic bioactivity Table 4a . Sixteen compounds that were active experimentally and belonged to the training set but were predicted not active for ER binding Table 4b . Fifteen Compounds that were not active experimentally and belonged to the training set but were predicted active for ER binding Table 5a . Twelve compounds that were active experimentally and belonged to the training set but were predicted not active for AR binding Table S3b . Eleven compounds that have ER binding at AC 50 < 1 µM for all the three mammalian nuclear receptor binding assays were also active in the uterotrophic assay. They also belong to the training set data used to derive the ER QSAR model. The in silico prediction results including the total domain information as well as in vitro assay data are given. 
